Erlotinib combined with cyclosporine in a liver-transplant recipient with epidermal growth factor receptor-mutated non-small cell lung cancer

J Thorac Oncol. 2009 Jan;4(1):138-9. doi: 10.1097/JTO.0b013e31819151e5.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / genetics
  • Carcinoma, Non-Small-Cell Lung / pathology
  • Cyclosporine / administration & dosage*
  • ErbB Receptors / genetics*
  • Erlotinib Hydrochloride
  • Humans
  • Liver Transplantation*
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / genetics
  • Lung Neoplasms / pathology
  • Male
  • Middle Aged
  • Mutation / genetics*
  • Quinazolines / administration & dosage

Substances

  • Quinazolines
  • Cyclosporine
  • Erlotinib Hydrochloride
  • ErbB Receptors